IPO registrations (S-1, F-1) · Registrants
INTELLIGENT BIO SOLUTIONS INC.
- SEC CIK
- 1725430 · filings on EDGAR ↗
- Former names
- GBS Inc. (2019–2022); Glucose Biosensor Systems (Greater China) Holdings, Inc. (2017–2019)
- Registration
- Form S-1, first filed 2019-07-05, last 2023-09-28; 4 initial registrations, 19 amendments
- Outcome
- Final prospectus filed 2020-12-28; declared effective 2020-12-22
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 135 W 41ST ST,, FLOOR 5, New York, NY 10036
- EIN
- 82-1512711
- Ticker
- INBS (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- INTELLIGENT BIO SOLUTIONS INC. on the corporate pages
Offering terms
- Proposed price range
- $16.00–$18.00 per share (S-1/A filed 2020-12-21)
- Final price
- $17.00 per share, within the range (424B4 filed 2020-12-28, an initial public offering)
- Shares sold
- 1,058,824
- Gross proceeds
- $21,600,013 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol GBS
- Lead underwriters
- Dawson James (388,236 shares)
- Syndicate
- James Securities, Inc; The Benchmark Company (352,941); ViewTrade (352,941); WestPark Capital, Inc (176,471)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: INTELLIGENT BIO SOLUTIONS INC. Fuzzy (name and state)
- Form 5500 plan sponsor: INTELLIGENT BIO SOLUTIONS INC. EXACT (EIN (EXACT))
- Form D issuer: INTELLIGENT BIO SOLUTIONS INC. EXACT (CIK (EXACT))
- SEC filer: GBS Inc. EXACT (CIK (EXACT))
Filings 35
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2019-07-05 | S-1 | S-1 (registration) | Glucose Biosensor Systems (Greater China) Holdings, Inc. | 0001493152-19-010287 ↗ |
| 2019-08-02 | S-1/A | S-1/A (amendment) | Glucose Biosensor Systems (Greater China) Holdings, Inc. | 0001493152-19-011559 ↗ |
| 2019-08-21 | S-1/A | S-1/A (amendment) | Glucose Biosensor Systems (Greater China) Holdings, Inc. | 0001493152-19-013224 ↗ |
| 2019-09-19 | S-1/A | S-1/A (amendment) | Glucose Biosensor Systems (Greater China) Holdings, Inc. | 0001493152-19-014290 ↗ |
| 2019-11-29 | S-1/A | S-1/A (amendment) | GBS Inc. | 0001493152-19-018555 ↗ |
| 2020-08-06 | S-1/A | S-1/A (amendment) | GBS Inc. | 0001493152-20-014782 ↗ |
| 2020-10-01 | S-1/A | S-1/A (amendment) | GBS Inc. | 0001641172-20-000008 ↗ |
| 2020-10-13 | S-1/A | S-1/A (amendment) | GBS Inc. | 0001493152-20-019265 ↗ |
| 2020-10-20 | S-1/A | S-1/A (amendment) | GBS Inc. | 0001493152-20-019661 ↗ |
| 2020-11-16 | S-1/A | S-1/A (amendment) | GBS Inc. | 0001493152-20-021371 ↗ |
| 2020-12-08 | S-1/A | S-1/A (amendment) | GBS Inc. | 0001493152-20-023086 ↗ |
| 2020-12-21 | S-1/A | S-1/A (amendment) | GBS Inc. | 0001493152-20-023971 ↗ |
| 2020-12-22 | S-1MEF | S-1MEF (added securities) | GBS Inc. | 0001493152-20-024168 ↗ |
| 2020-12-22 | EFFECT | EFFECT (declared effective) | GBS Inc. | 9999999995-20-003605 ↗ |
| 2020-12-28 | 424B4 | 424B4 (final prospectus) | GBS Inc. | 0001493152-20-024279 ↗ |
| 2021-01-21 | S-1 | S-1 (registration) | GBS Inc. | 0001493152-21-001461 ↗ |
| 2021-02-16 | S-1/A | S-1/A (amendment) | GBS Inc. | 0001493152-21-003962 ↗ |
| 2021-03-10 | S-1/A | S-1/A (amendment) | GBS Inc. | 0001493152-21-005711 ↗ |
| 2021-03-31 | EFFECT | EFFECT (declared effective) | GBS Inc. | 9999999995-21-001225 ↗ |
| 2022-04-20 | EFFECT | EFFECT (declared effective) | GBS Inc. | 9999999995-22-001042 ↗ |
| 2023-06-06 | S-1 | S-1 (registration) | INTELLIGENT BIO SOLUTIONS INC. | 0001493152-23-020306 ↗ |
| 2023-06-23 | S-1/A | S-1/A (amendment) | INTELLIGENT BIO SOLUTIONS INC. | 0001493152-23-022246 ↗ |
| 2023-06-27 | EFFECT | EFFECT (declared effective) | INTELLIGENT BIO SOLUTIONS INC. | 9999999995-23-001859 ↗ |
| 2023-07-12 | S-1 | S-1 (registration) | INTELLIGENT BIO SOLUTIONS INC. | 0001493152-23-024339 ↗ |
| 2023-07-27 | S-1/A | S-1/A (amendment) | INTELLIGENT BIO SOLUTIONS INC. | 0001493152-23-025721 ↗ |
| 2023-09-05 | S-1/A | S-1/A (amendment) | INTELLIGENT BIO SOLUTIONS INC. | 0001493152-23-031657 ↗ |
| 2023-09-11 | S-1/A | S-1/A (amendment) | INTELLIGENT BIO SOLUTIONS INC. | 0001493152-23-032206 ↗ |
| 2023-09-22 | S-1/A | S-1/A (amendment) | INTELLIGENT BIO SOLUTIONS INC. | 0001493152-23-033392 ↗ |
| 2023-09-28 | S-1/A | S-1/A (amendment) | INTELLIGENT BIO SOLUTIONS INC. | 0001493152-23-034666 ↗ |
| 2023-09-29 | EFFECT | EFFECT (declared effective) | INTELLIGENT BIO SOLUTIONS INC. | 9999999995-23-002867 ↗ |
| 2023-10-03 | 424B4 | 424B4 (final prospectus) | INTELLIGENT BIO SOLUTIONS INC. | 0001493152-23-035269 ↗ |
| 2024-03-15 | EFFECT | EFFECT (declared effective) | INTELLIGENT BIO SOLUTIONS INC. | 9999999995-24-000672 ↗ |
| 2024-03-27 | EFFECT | EFFECT (declared effective) | INTELLIGENT BIO SOLUTIONS INC. | 9999999995-24-000745 ↗ |
| 2025-09-09 | EFFECT | EFFECT (declared effective) | INTELLIGENT BIO SOLUTIONS INC. | 9999999995-25-002895 ↗ |
| 2025-09-10 | EFFECT | EFFECT (declared effective) | INTELLIGENT BIO SOLUTIONS INC. | 9999999995-25-002904 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-12-21 | S-1/A | registration statement | $16.00–$18.00 | $8.50 | 1,058,824 | $9,000,004 | Nasdaq GBS | 2 | primary document; range, price line, shares headline, proceeds computed, cover names 2 | document ↗ |
| 2020-12-28 | 424B4 | final prospectus | $17.00 | - | $21,600,013 | Nasdaq GBS | 5 | primary document; price sentence, proceeds table, underwriting table 4, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Boyages Steven Constantine | Director; Director,Officer | Interim CEO and Chairperson | 3 | 2020–2026 | |
| FISHER LAWRENCE B | Director | 2 | 2020–2022 | ||
| Gavrilenko Victoria | Director | 2 | 2020–2021 | ||
| Hurd Jonathan Scott | Director | 3 | 2020–2026 | ||
| Kempler Leonard Victor | Director | 1 | 2020 | ||
| Life Science Biosensor Diagnostics Pty Ltd | Other; TenPercentOwner | 31 | 2020–2022 | ||
| Margelis George | Director | 2 | 2020–2022 | ||
| Parmakellis Tom | Director | 5 | 2020–2022 | ||
| Sakiris Spiro Kevin | Officer | Chief Financial Officer; ChiefFinancial Officer | 15 | 2020–2026 | |
| Sessler Jonathan Lawrence | Director | 1 | 2020 | ||
| Simeonidis Harry | Director,Officer; Officer | CEO; CEO, President; Chief Executive Officer; President | 5 | 2020–2026 | |
| TOWERS CHRISTOPHER | Director | 4 | 2020–2023 | ||
| Isenberg Jason | Director | 2 | 2022–2026 | ||
| JENKINS DAVID A | Director | 1 | 2022 | ||
| Gary W. Rollins Foundation | TenPercentOwner | 1 | 2023 | ||
| Ma-Ran Foundation | TenPercentOwner | 1 | 2023 | ||
| Fraser Nicola Marion | Director | 2 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-09-14 | INTELLIGENT BIO SOLUTIONS INC. | Other Health Care | $4,979,631 | $4,979,631 | 1 | 1 |
| 2026-01-13 | INTELLIGENT BIO SOLUTIONS INC. | Other Health Care | $9,978,059 | $9,978,059 | 2 | 1 |
| 2025-08-11 | INTELLIGENT BIO SOLUTIONS INC. | Other Health Care | $3,839,356 | $3,839,356 | 7 | 1 |
| 2024-03-22 | INTELLIGENT BIO SOLUTIONS INC. | Other Health Care | $10,100,683 | $10,100,683 | 8 | 1 |
| 2022-10-18 | GBS Inc. | Other Health Care | Indefinite | $0 | 36 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | INTELLIGENT BIO SOLUTIONS INC. | NY | State business registries | name and state |
| Form D issuer | INTELLIGENT BIO SOLUTIONS INC. | NY | Form D private offerings | CIK (EXACT) |
| SEC filer | INTELLIGENT BIO SOLUTIONS INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | INTELLIGENT BIO SOLUTIONS INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, NY first:
- SWISSRAY INTERNATIONAL INC NY
- BIOPHAN TECHNOLOGIES INC NY
- ANGIODYNAMICS INC NY
- DarioHealth Corp. NY
- iNeedMD Holdings, Inc. NY
- Nemaura Medical Inc. NY
- PAVmed Inc. NY
- Beyond Air, Inc. NY
- OMNIA WELLNESS INC. NY
- Lucid Diagnostics Inc. NY
In other datasets, the same topic (Technology) in NY:
- Lobbying client: 1ST ROCHDALE COOPERATIVE GROUP LTD (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology